Insulin-like growth factor-1 (IGF-1) is an active polypeptide protein that closely resembles the structural sequence of insulin and is involved in a variety of metabolic processes in the body.

We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Impact of Lifestyle Changes: Making dietary changes after a prostate cancer diagnosis can be beneficial in preventing ...

Height has been linked to an increased risk of certain cancers, including pancreatic, uterine, and breast cancer, due to ...

In recent years, protein supplements have gained popularity among fitness enthusiasts and bodybuilders looking to build ...

Shares of Infinity Natural Resources jumped almost 11% in their NYSE debut, valuing the oil and natural gas producer at $1.3B. The listing ...

Jabil acquires Pharmaceutics International to enhance commercial prospects in the emerging market of CDMO services.

A protein called B cell lymphoma 6 could be key to maintaining healthy muscle mass and potentially could be used to combat ...

Topline results were announced from a phase 2/3 trial evaluating linsitinib for the treatment of moderate to severe thyroid eye disease.

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...

An estimated 42 million people in India suffer from thyroid problems, an autoimmune condition that has grown very common. The most frequent cause is thought to be iodine deficiency brought on by ...

AURORA, Colo. -- Among those at low-risk for preterm birth, a blood-based biomarker screening test during the second trimester identified pregnancies at higher risk for preterm birth, and a treatment ...